Christian Elling

Managing Partner Lundbeckfonden BioCapital

Christian E. Elling heads the early stage biotech investment unit Lundbeckfonden BioCapital.

Christian was previously co-founder, Vice President of Biology and Development and later CEO of 7TM Pharma. Christian received his early training in biochemistry and received his PhD in pharmacology from University of Copenhagen, Denmark.


Member of the board of directors: Cytoki, IO Biotech, NMD Pharma, SNIPR Biome

Former member of the board of directors: AFYX Therapeutics, EpiTherapeutics, Inagen

Christian Ellings portfolio

Christian Elling
+45 2062 1276
cee@lundbeckfonden.com